These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 35659828)

  • 1. Impaired bone health as a co-morbidity of epilepsy.
    Andersen NB; Jørgensen NR
    Best Pract Res Clin Rheumatol; 2022 Sep; 36(3):101755. PubMed ID: 35659828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for bone health in epilepsy.
    Sheth RD; Harden CL
    Epilepsia; 2007; 48 Suppl 9():39-41. PubMed ID: 18047601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications associated with the use of enzyme-inducing and non-enzyme-inducing anti-seizure medications in the Japanese population: A retrospective cohort study.
    Gao J; Seki T; Usami K; Fan D; Ikeda A; Kawakami K
    Epilepsy Behav; 2022 Apr; 129():108610. PubMed ID: 35231856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis Associated with Epilepsy and the Use of Anti-Epileptics-a Review.
    Petty SJ; Wilding H; Wark JD
    Curr Osteoporos Rep; 2016 Apr; 14(2):54-65. PubMed ID: 26879819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic bone disease in patients with epilepsy and the use of antiepileptic drugs - Insight from a Danish cross-sectional study.
    Baddoo DR; Mills AA; Kullab RB; Al-Mashat H; Andersen NB; Jørgensen NR; Diemar SS
    Seizure; 2021 Mar; 86():29-34. PubMed ID: 33517239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone health in women with epilepsy: clinical features and potential mechanisms.
    Pack AM; Walczak TS
    Int Rev Neurobiol; 2008; 83():305-28. PubMed ID: 18929090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of epilepsy in younger and older adults: Demographic differences and prescribing patterns of anti-seizure medications in Canada.
    Haris A; Bachour K; Hopkins RB; Tarride JE; Keezer MR
    Epilepsy Res; 2022 Aug; 184():106941. PubMed ID: 35785633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone health in people with epilepsy: is it impaired and what are the risk factors?
    Pack A
    Seizure; 2008 Mar; 17(2):181-6. PubMed ID: 18187347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy and osteoporosis risk.
    Dussault PM; Lazzari AA
    Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):395-401. PubMed ID: 28857845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of bone metabolism in epilepsy.
    Uçan Tokuç FE; Fatma G; Abidin E; Yasemin GB
    Ideggyogy Sz; 2021 Jul; 74(7-08):257-265. PubMed ID: 34370412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of age when initiating anti-seizure medication therapy on fragility fracture risk for children with epilepsy.
    Whitney DG; Kalia V; Rajapakse CS; Fedak Romanowski EM; Caird MS; Hurvitz EA; Jepsen KJ
    Bone; 2021 Aug; 149():115996. PubMed ID: 33962082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone health in adults with epilepsy.
    Svalheim S; Røste LS; Nakken KO; Taubøll E
    Acta Neurol Scand Suppl; 2011; (191):89-95. PubMed ID: 21711263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of bone turnover in patients with epilepsy and their relationship to management of bone diseases induced by antiepileptic drugs.
    Hamed SA
    Expert Rev Clin Pharmacol; 2016; 9(2):267-86. PubMed ID: 26589104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the effect of anticonvulsant medications on bone mineral density and fracture risk.
    Lee RH; Lyles KW; Colón-Emeric C
    Am J Geriatr Pharmacother; 2010 Feb; 8(1):34-46. PubMed ID: 20226391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unanticipated improvement in seizure control in drug-resistant epilepsy- real world observations.
    Moloney PB; Costello DJ
    Seizure; 2021 Jan; 84():60-65. PubMed ID: 33285361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy.
    Beerhorst K; Tan IY; De Krom M; Verschuure P; Aldenkamp AP
    Acta Neurol Scand; 2013 Oct; 128(4):273-80. PubMed ID: 23461582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone disease during chronic antiepileptic drug therapy: general versus specific risk factors.
    Beerhorst K; van der Kruijs SJ; Verschuure P; Tan IY; Aldenkamp AP
    J Neurol Sci; 2013 Aug; 331(1-2):19-25. PubMed ID: 23706474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiseizure medications for post-stroke epilepsy: A real-world prospective cohort study.
    Tanaka T; Fukuma K; Abe S; Matsubara S; Motoyama R; Mizobuchi M; Yoshimura H; Matsuki T; Manabe Y; Suzuki J; Ikeda S; Kamogawa N; Ishiyama H; Kobayashi K; Shimotake A; Nishimura K; Onozuka D; Koga M; Toyoda K; Murayama S; Matsumoto R; Takahashi R; Ikeda A; Ihara M;
    Brain Behav; 2021 Sep; 11(9):e2330. PubMed ID: 34423590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density with lamotrigine monotherapy for epilepsy.
    Sheth RD; Hermann BP
    Pediatr Neurol; 2007 Oct; 37(4):250-4. PubMed ID: 17903668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.